Status:
UNKNOWN
Effect of Terlipressin on the Incidence of Early Postoperative Acute Kidney Injury in Liver Transplantation Patients
Lead Sponsor:
Beijing Tsinghua Chang Gung Hospital
Conditions:
Acute Kidney Injury
Liver Transplant; Complications
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to evaluate the effect of intraoperative terlipressin on the incidence of early postoperative acute kidney injury in deceased doner liver transplantation. Patients w...
Detailed Description
acute kidney injury is a relatively common complication in patients with liver transplantation. Most centers have established prediction models for acute kidney injury after liver transplantation, but...
Eligibility Criteria
Inclusion
- 1\) Patients who plan to undergo liver transplantation in our hospital 2) Patients or family members sign informed consent
Exclusion
- Patients \<18 years old;② Patients undergoing autologous liver transplantation or combined transplantation;③ Patients with lower extremity artery stenosis;(4) Patients with severe heart disease、lung disease、kidney disease;⑤ Patients with severe lung disease;⑥ Patients who used renal replacement therapy before surgery;⑦ the depth of one kidney from the body surface is greater than 4cm;⑧ Patients treated with terlipressin within 2 weeks before surgery⑨ Patients allergic to terlipressin.
Key Trial Info
Start Date :
August 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06108362
Start Date
August 18 2023
End Date
June 30 2024
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tsinghua Chang Gung Hospital
Beijing, Beijing Municipality, China, 1000000